Australia's ReNerve gains on partnership with Indian firm

Renerve

10/04/2025 03:18

** Shares of ReNerve RNV.AX rise 9.5% to A$0.115

** Stock set for its strongest session since March 28, if current trends hold

** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market

** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030

** Stock down 34.3% YTD, including current session's moves

 (Reporting by Manasi Dasa in Bengaluru)

 ((Manasi.DasaSundeep@thomsonreuters.com;))